Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Topical cyclosporin-A is recommended for severe alopecia areata.

Topical cyclosporine lotion led to hair regrowth in a man with alopecia universalis.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

Early diagnosis and treatment can lessen the impact of cicatricial alopecia.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

These hair loss conditions might be part of a spectrum, not separate issues.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Classifying alopecia helps diagnose and treat different types of hair loss accurately.

Topical cyclosporine lotion led to noticeable hair regrowth in alopecia universalis.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

CCCA can occur in children and needs early diagnosis to prevent permanent hair loss.

Platelet-Rich Plasma (PRP) can improve hair loss in cicatricial alopecia cases, but treatment must be ongoing and results vary among patients.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Baricitinib is not very effective for severe alopecia areata.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

A rare scalp condition, cutis verticis gyrata, was found in a woman with primary scarring alopecia.

Alopecia areata is an autoimmune disease that targets hair follicles.

Early diagnosis and treatment can reduce cicatricial alopecia in middle-aged individuals, especially females.